| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |